Home › Diffuse Intrinsic Pontine Glioma › New York
Diffuse Intrinsic Pontine Glioma clinical trials in New York
3 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in New York.
Cities in New York
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Roswell Park Cancer Institute, Buffalo
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944Combination Therapy for the Treatment of Diffuse Midline Gliomas
- New York University, New York
RecruitingPhase 2
Ages 2 to 39 · All sexes · Updated Jun 26, 2026 · NCT05009992FUS Etoposide for DMG
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 4 to 21 · All sexes · Updated Jan 28, 2026 · NCT05762419From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.